A Phase II, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Safety and Efficacy of KX-826 Tincture for Topical Use in Chinese Adult Female Patients With Androgenetic Alopecia (AGA)
Latest Information Update: 24 May 2024
At a glance
- Drugs Pyrilutamide (Primary)
- Indications Alopecia
- Focus Therapeutic Use
- 07 May 2024 Status changed to completed According to ClinicalTrials.gov record.
- 28 Aug 2023 According to a Kintor Pharmaceutical Limited media release, data from this study was presented at CHRS 2023
- 28 Aug 2023 According to a Kintor Pharmaceutical Limited media release, this study will be presented at EADV 2023.